Lumos Diagnostics Holdings Limited (LDX.AX)
AUD 0.03
(13.64%)
AUD 0.03
(13.64%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -5 Million USD | 51.07% |
| 2023 | -10.23 Million USD | 52.38% |
| 2022 | -21.49 Million USD | -95.36% |
| 2021 | -11 Million USD | -2.63% |
| 2020 | -10.71 Million USD | -271.22% |
| 2019 | -2.88 Million USD | -124.4% |
| 2018 | -1.28 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | -354 Thousand USD | 0.0% |
| 2024 Q1 | -2.81 Million USD | -46.12% |
| 2024 Q2 | -2.19 Million USD | 22.17% |
| 2024 Q3 | -354 Thousand USD | 83.84% |
| 2023 Q2 | -2.9 Million USD | 0.0% |
| 2023 FY | -10.23 Million USD | 52.38% |
| 2023 Q4 | -1.92 Million USD | 0.0% |
| 2023 Q3 | -1.92 Million USD | 33.76% |
| 2023 Q1 | -2.9 Million USD | 63.71% |
| 2022 Q2 | -5.43 Million USD | 0.0% |
| 2022 Q1 | -5.43 Million USD | -29.06% |
| 2022 FY | -21.49 Million USD | -95.36% |
| 2022 Q4 | -8.01 Million USD | 0.0% |
| 2022 Q3 | -8.01 Million USD | -47.45% |
| 2021 FY | -11 Million USD | -2.63% |
| 2021 Q4 | -4.21 Million USD | 0.0% |
| 2021 Q3 | -4.21 Million USD | -226.76% |
| 2021 Q2 | -1.28 Million USD | 0.0% |
| 2021 Q1 | -1.28 Million USD | 62.6% |
| 2020 Q4 | -3.44 Million USD | -12.22% |
| 2020 Q2 | -1.94 Million USD | -3.96% |
| 2020 Q1 | -1.87 Million USD | 0.0% |
| 2020 FY | -10.71 Million USD | -271.22% |
| 2020 Q3 | -3.07 Million USD | -57.9% |
| 2019 FY | -2.88 Million USD | -124.4% |
| 2018 FY | -1.28 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Australian Clinical Labs Limited | 56.9 Million AUD | 108.801% |
| BCAL Diagnostics Limited | -5.44 Million AUD | 8.063% |
| Genetic Signatures Limited | -22.33 Million AUD | 77.576% |
| Genetic Technologies Limited | -6.53 Million AUD | 23.392% |
| Healius Limited | 39.7 Million AUD | 112.615% |
| Imagion Biosystems Limited | -15.81 Million AUD | 68.332% |
| Integral Diagnostics Limited | 5.36 Million AUD | 193.311% |
| INOVIQ Ltd | -9.51 Million AUD | 47.343% |
| Microba Life Sciences Limited | -26.84 Million AUD | 81.343% |
| Monash IVF Group Limited | -5.34 Million AUD | 6.287% |
| Rhythm Biosciences Limited | -6.7 Million AUD | 25.334% |
| Sonic Healthcare Limited | 816.45 Million AUD | 100.613% |